Clinical trial
Validation of the ProSomnus® RPMO2 Pulse Oximeter Device
NCT06267976 is registered in ClinicalTrials.gov with ProSomnus Sleep Technologies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Validation of the ProSomnus® RPMO2 Pulse Oximeter Device
- Lead sponsor
- ProSomnus Sleep Technologies
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 10, 2024
- Completion date
- June 30, 2025
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy